Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Inhaled steroids in children may cause excessive hair growth and not always go away after stopping the medication.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Doctors often diagnose Cushing's syndrome late, which worsens symptoms; earlier detection is needed.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Hormonal factors may affect female hair loss, needing further research and treatment ideas.

Pregnancy with Cushing's syndrome is rare and risky for both mother and baby, needing early diagnosis and treatment.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Managing multiple autoimmune diseases in one patient is extremely challenging.

Chesapeake Bay retrievers' hair loss is likely a breed-specific, hereditary condition linked to abnormal steroid levels and distinct skin changes.

Hirsutism requires identifying the cause to choose the right treatment, which may include medications like oral contraceptives or dexamethasone.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

Hair loss, known as androgenic alopecia, can start in teenage years and may not always be hormone-related. It's important to do extra tests in young cases and remember it can greatly affect a teenager's mental health.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and inhaled budesonide.

Stress hormone corticosterone suppresses hair growth by affecting stem cell activity and Gas6 protein expression.

An 80-year-old woman's severe hair loss was caused by a hormone-secreting ovarian tumor.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Individualized treatment is crucial for managing hirsutism in women.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.